Interleukin—1 receptor antagonist and uses thereof
US6541623B1 · kind B1 · utility
12Cited by
24References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2000 |
| Grant date | Apr 1, 2003 |
| Priority date | — |
| Expiry date | May 22, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel nucleic acids, the novel polypeptide sequences encoded by these nucleic acids and uses thereof. These novel polynucleotide and polypeptide sequences were determined to be a novel Interleukin-1 Receptor Antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.